bucladesine has been researched along with epirubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Yamada, T; Zukeyama, N | 1 |
2 other study(ies) available for bucladesine and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury.
Topics: 1-Methyl-3-isobutylxanthine; Albuterol, Ipratropium Drug Combination; Animals; Apoptosis; Bucladesine; Caspase 3; Caspase 7; Cell Survival; Cells, Cultured; Colforsin; Cyclic AMP; Endothelial Cells; Epirubicin; Lipid Peroxidation; Lipid Peroxides; Swine | 2016 |